{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:14:53Z","timestamp":1790727293588,"version":"4.1.0"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T00:00:00Z","timestamp":1601942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81704099"],"award-info":[{"award-number":["81704099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774096"],"award-info":[{"award-number":["81774096"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803694"],"award-info":[{"award-number":["81803694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["QNRC2016642"],"award-info":[{"award-number":["QNRC2016642"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013059","name":"Jiangsu Provincial Medical Youth Talent","doi-asserted-by":"publisher","award":["LGY2018061"],"award-info":[{"award-number":["LGY2018061"]}],"id":[{"id":"10.13039\/501100013059","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2632020ZD07"],"award-info":[{"award-number":["2632020ZD07"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.579228","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T12:57:20Z","timestamp":1601989040000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Fibrinogen-Like Protein 1 Is a Novel Biomarker for Predicting Disease Activity and Prognosis of Rheumatoid Arthritis"],"prefix":"10.3389","volume":"11","author":[{"given":"Shijia","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunke","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deshun","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxiang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WenFeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,6]]},"reference":[{"key":"B1","first-page":"S295","article-title":"Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis","volume":"18","author":"Gibofsky","year":"2012","journal-title":"Am J Manag Care"},{"key":"B2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/ard.2003.012575","article-title":"Patients with rheumatoid arthritis in clinical care","volume":"63","author":"Smolen","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1136\/ard.2009.123919","article-title":"Treating rheumatoid arthritis to target: recommendations of an international task force","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ncprheum0246","article-title":"Monitoring disease activity of rheumatoid arthritis in clinical practice: contributions from clinical trials","volume":"2","author":"Zatarain","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1136\/ard.2007.069690","article-title":"Responsiveness of patient reported outcomes including fatigue, sleep quality, activity limitation, and quality of life following treatment with abatacept for rheumatoid arthritis","volume":"67","author":"Wells","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"B9","first-page":"S85","article-title":"Optimisation of assessment for rheumatic diseases in clinical trials, observational studies and routine clinical care","volume":"32","author":"Pincus","year":"","journal-title":"Clin Exp Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1021\/pr500467d","article-title":"Urinary proteome profile predictive of disease activity in rheumatoid arthritis","volume":"13","author":"Kang","year":"2014","journal-title":"J Proteome Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"S214","DOI":"10.1002\/art.11407","article-title":"Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI)","volume":"49","author":"Fransen","year":"2003","journal-title":"Arthritis Care Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"key":"B14","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1021\/acs.jproteome.9b00676","article-title":"Discovery of potential serum protein biomarkers in ankylosing spondylitis using tandem mass tag-based quantitative proteomics","volume":"19","author":"Liu","year":"2020","journal-title":"J Proteome Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1006\/bbrc.1993.1678","article-title":"Molecular cloning and initial characterization of a novel fibrinogen-related gene, HFREP-1","volume":"193","author":"Yamamoto","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"B17","doi-asserted-by":"publisher","first-page":"13335","DOI":"10.1074\/jbc.M806393200","article-title":"Specific expression and regulation of hepassocin in the liver and down-regulation of the correlation of hnf1alpha with decreased levels of hepassocin in human hepatocellular carcinoma","volume":"284","author":"Yu","year":"2009","journal-title":"J Biol Chem"},{"key":"B18","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1136\/gut.2008.171124","article-title":"Recombinant human hepassocin stimulates proliferation of hepatocytes in vivo and improves survival in rats with fulminant hepatic failure","volume":"59","author":"Li","year":"2010","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.cellsig.2014.04.013","article-title":"Hepassocin activates the EGFR\/ERK cascade and induces proliferation of L02 cells through the Src-dependent pathway","volume":"26","author":"Gao","year":"2014","journal-title":"Cell Signal"},{"key":"B20","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/gut.2009.201020","article-title":"Hepassocin as a treatment for fulminant hepatic failure: will it translate from rats to human?","volume":"59","author":"Calvaruso","year":"2010","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jhep.2013.06.004","article-title":"The role of hepassocin in the development of non-alcoholic fatty liver disease","volume":"59","author":"Wu","year":"2013","journal-title":"J Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1007\/s00125-016-3991-7","article-title":"A novel hepatokine, HFREP1, plays a crucial role in the development of insulin resistance and type 2 diabetes","volume":"59","author":"Wu","year":"2016","journal-title":"Diabetologia."},{"key":"B23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mce.2017.10.014","article-title":"Hyperlipidemia-induced hepassocin in the liver contributes to insulin resistance in skeletal muscle","volume":"470","author":"Jung","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1096\/fj.201901925R","article-title":"Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity","volume":"34","author":"Wu","year":"2020","journal-title":"FASEB J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"key":"B26","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13075-017-1309-x","article-title":"Interleukin-10-producing LAG3+ regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis","volume":"19","author":"Nakachi","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s42358-019-0089-1","article-title":"High prevalence of obesity in rheumatoid arthritis patients: association with disease activity, hypertension, dyslipidemia and diabetes, a multi-center study","volume":"59","author":"de Resende Guimar\u00e3es","year":"2019","journal-title":"Adv Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1136\/annrheumdis-2016-209223","article-title":"Disease activity is associated with reduced left ventricular systolic myocardial function in patients with rheumatoid arthritis","volume":"76","author":"Midtb\u00f8","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.579228\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T12:57:24Z","timestamp":1601989044000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.579228\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,6]]},"references-count":29,"alternative-id":["10.3389\/fimmu.2020.579228"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.579228","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,6]]},"article-number":"579228"}}